Children with childhood leukemia benefit from prophylactic antibiotics
Prophylactic antibiotics significantly reduce the risk of serious bacterial infections in children during the critical first month of treatment for acute lymphoblastic leukemia (ALL), the most common childhood cancer, according to a U.S. and Canadian study led by investigators from Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
Read more here: http://www.eurekalert.org/pub_releases/2015-12/dci-cwc120315.php